Business Context and Reporting Period
Company: Zimmer Holdings, Inc. (Note: Filing lists "Zimmer Holdings, Inc." while metadata references "Zimmer Biomet Holdings, Inc.")
Filing Type: Form 8-K (Current Report)
Date of Report: October 28, 2010
Reporting Period: Quarter ended September 30, 2010
This filing serves to report the results of operations for the third quarter of 2010. The detailed financial data is contained in an attached press release (Exhibit 99.1) and is incorporated by reference.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide specific numerical values for revenue, net income, cash flow, margins, debt, or liquidity. These figures are located in the attached Exhibit 99.1 (Press Release) which is referenced but not included in the provided text.
Non-GAAP Measures Discussed: The filing details the use of non-GAAP financial measures in the attached press release, including:
- Constant Currency Sales: Sales translated at predetermined exchange rates to exclude foreign currency fluctuations.
- Adjusted Net Earnings and Diluted EPS: Adjusted to exclude specific items such as acquisition, integration, realignment expenses, inventory step-up, and provisions for Durom Acetabular Component product claims.
Material Changes and Adjustments
The filing outlines specific adjustments made to financial measures for the periods ended September 30, 2010, and September 30, 2009, to facilitate comparison:
- Q3 2010 Adjustments: Excluded acquisition, integration, realignment, and other expenses (net of tax).
- YTD 2010 Adjustments: Excluded inventory step-up, acquisition, integration, realignment, other expenses, and a provision for Durom Acetabular Component product claims (net of tax).
- YTD 2009 Adjustments: Excluded the items listed above plus a net curtailment and settlement gain recognized in Q2 2009.
Guidance, Outlook, and Risks
Guidance: The filing mentions that the attached press release includes projected adjusted diluted EPS for the quarter ended December 31, 2010, and for the full year 2010. Specific guidance numbers are not present in this text.
Risks and Contingencies: The filing explicitly references a provision for known and anticipated claims related to the Durom Acetabular Component product, indicating a material contingency affecting earnings.
Management Commentary: Management emphasizes that non-GAAP measures should be considered in addition to, not as a substitute for, GAAP measures. All non-GAAP measures are reconciled to GAAP in the attached press release.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the attached Exhibit 99.1 (Press Release).
- Review the reconciliation of non-GAAP adjusted earnings to GAAP earnings to understand the magnitude of the Durom product claim provision and restructuring costs.
- Confirm the projected full-year 2010 adjusted diluted EPS guidance provided in the press release.
- Assess the impact of foreign currency exchange rates on reported sales growth by comparing GAAP sales to constant currency sales.